SNCA and Parkinson disease: The major constituent of GCI is α-synuclein, and therefore MSA is classified as an α-synucleinopathy, a group of neurodegenerative diseases that also includes Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) [5, 26, 81].